Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts124/v4/f7/00/80/f70080dc-f58a-d571-7184-f6aa56fc535a/mza_8875933359820743369.jpg/600x600bb.jpg
Health Law Diagnosed
Mintz
7 episodes
2 months ago
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
Show more...
Business
RSS
All content for Health Law Diagnosed is the property of Mintz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.
Show more...
Business
https://i1.sndcdn.com/artworks-sq7ly3WYvQyevAdH-mouzlQ-t3000x3000.jpg
Women Leaders in Health Care: Investing in Women’s Health
Health Law Diagnosed
24 minutes 33 seconds
1 year ago
Women Leaders in Health Care: Investing in Women’s Health
In the latest episode of Health Law Diagnosed – Women Leaders in Health Care, a series that brings together women leaders for discussions on timely key issues and reflections on developing a career in the industry, host Bridgette Keller leads a conversation around investing in women's health. She is joined by Lauren Edgerton, Healthcare Director at Piper Sandler, and Kathryne Cooper, Partner at Jumpstart Nova. Lauren and Kathryne discuss the areas of women's health that have seen the most growth in the last few years, how they evaluate a potential investment including their standard criteria, and how you can get involved in investing in women's health care. Our guests also cover topics such as: • What are the unique challenges in raising capital for companies that focus on women's health? • Why do you think women’s health has historically been underfunded compared to other sectors, and what can be done to improve funding for women’s health? • What advice would you give to women interested in a career in investing in health care?
Health Law Diagnosed
In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.